Literature DB >> 7216472

Staphylococcal scarlet fever: role of pyrogenic exotoxins.

P M Schlievert.   

Abstract

Staphylococcal pyrogenic exotoxin (PE) types A and B were tested for their role in production of a scarlatiniform rash. The PEs elicited minimal skin reactions after intracutaneous injection into animals not presensitized to the toxins. In contrast, erythematous injection into animals not presensitized to the toxins. In contrast, erythematous and edematous rashes were produced after administration of either PE to animals presensitized to homologous toxin. After 3 to 4 days, the erythematous areas showed membranous desquamation. Staphylococcal PEs also enhanced delayed and Arthus hypersensitivity skin reactions developed against unrelated proteins; the reactions subsequently desquamated. In addition, animals previously sensitized to either staphylococcal PE type developed scarlatiniform rashes after challenged with heterologous staphylococcal or any group A streptococcal PE. The data suggest that staphylococcal PEs produce scarlet fever-like rashes comparable to group A streptococcal PEs and that all PE types contain a common core moiety against which delayed hypersensitivity may be developed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7216472      PMCID: PMC351371          DOI: 10.1128/iai.31.2.732-736.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Mucocutaneous lymph node syndrome in the United States.

Authors:  M E Melish; R M Hicks; E J Larson
Journal:  Am J Dis Child       Date:  1976-06

2.  Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus.

Authors:  P M Schlievert; D J Schoettle; D W Watson
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

3.  Heterogeneity of group A streptococcal pyrogenic exotoxin type B.

Authors:  E L Barsumian; C M Cunningham; P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

4.  Scarlet fever and necrotizing fascitis caused by coagulase-positive hemolytic Staphylococcus aureus, phage type 85.

Authors:  R V McCloskey
Journal:  Ann Intern Med       Date:  1973-01       Impact factor: 25.391

5.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

6.  Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin.

Authors:  P M Schlievert; D J Schoettle; D W Watson
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved.

Authors:  C M Cunningham; D W Watson
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

8.  Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins.

Authors:  E L Barsumian; P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

9.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

10.  A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock.

Authors:  Y B Kim; D W Watson
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

View more
  5 in total

1.  Staphylococcal enterotoxins in scarlet fever complicating chickenpox.

Authors:  M G Brook; B A Bannister
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

2.  Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

Review 3.  Models matter: the search for an effective Staphylococcus aureus vaccine.

Authors:  Wilmara Salgado-Pabón; Patrick M Schlievert
Journal:  Nat Rev Microbiol       Date:  2014-07-07       Impact factor: 60.633

4.  The incidence of scarlet fever.

Authors:  E M Perks; R T Mayon-White
Journal:  J Hyg (Lond)       Date:  1983-10

5.  Recovery of Staphylococcus aureus from multiple body sites in menstruating women.

Authors:  L W Lansdell; D Taplin; T E Aldrich
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.